Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network
Identifieur interne : 000383 ( Main/Exploration ); précédent : 000382; suivant : 000384Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network
Auteurs : M. Rondy ; J. Castilla ; O. Launay [France] ; S. Costanzo ; C. Ezpeleta ; F. Galtier [France] ; K. Gaetano DonatiSource :
- Human Vaccines & Immunotherapeutics [ 2164-5515 ] ; 2016-02-02.
English descriptors
Abstract
We conducted a multicentre test negative case control study to estimate the 2013–14 influenza vaccine effectiveness (IVE) against hospitalised laboratory confirmed influenza in 12 hospitals in France, Italy and Spain. We included all ≥18 years hospitalised patients targeted by local influenza vaccination campaign reporting an influenza-like illness within 7 days before admission. We defined as cases patients RT-PCR positive for influenza and as controls those negative for all influenza virus. We used a logistic regression to calculate IVE adjusted for country, month of onset, chronic diseases and age. We included 104 A(H1N1)pdm09, 157 A(H3N2) cases and 585 controls. The adjusted IVE was 42.8% (95%CI: 6.3;65;0) against A(H1N1)pdm09. It was respectively 61.4% (95%CI: −1.9;85.4), 39.4% (95%CI: −32.2;72.2) and 19.7% (95%CI:-148.1;74.0) among patients aged 18–64, 65–79 and ≥80 years. The adjusted IVE against A(H3N2) was 38.1% (95%CI: 8.3;58.2) overall. It was respectively 7.8% (95%CI: −145.3;65.4), 25.6% (95%CI: −36.0;59.2) and 55.2% (95%CI: 15.4;76.3) among patients aged 18–64, 65–79 and ≥80 years. These results suggest a moderate and age varying effectiveness of the 2013–14 influenza vaccine to prevent hospitalised laboratory-confirmed influenza. While vaccination remains the most effective prevention measure, developing more immunogenic influenza vaccines is needed to prevent severe outcomes among target groups. © 2016 Taylor & Francis.
Url:
DOI: 10.1080/21645515.2015.1126013
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: 000207
- to stream Hal, to step Curation: 000207
- to stream Hal, to step Checkpoint: 000092
- to stream Main, to step Merge: 000383
- to stream Main, to step Curation: 000383
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network</title>
<author><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M." last="Rondy">M. Rondy</name>
</author>
<author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J." last="Castilla">J. Castilla</name>
</author>
<author><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O." last="Launay">O. Launay</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-2593" status="OLD"> <orgName>CIC - Biotherapie - AP-HP (cochin - Pasteur)</orgName>
<desc> <address> <addrLine>Hopital Cochin PARIS V 27, Rue du Faubourg Saint-Jacques 75679 PARIS CEDEX 14</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="CBT505" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="CBT505" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S." last="Costanzo">S. Costanzo</name>
</author>
<author><name sortKey="Ezpeleta, C" sort="Ezpeleta, C" uniqKey="Ezpeleta C" first="C." last="Ezpeleta">C. Ezpeleta</name>
</author>
<author><name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F." last="Galtier">F. Galtier</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-303483" status="VALID"> <orgName>CHU Saint-Eloi</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Gaetano Donati, K" sort="Gaetano Donati, K" uniqKey="Gaetano Donati K" first="K." last="Gaetano Donati">K. Gaetano Donati</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01380416</idno>
<idno type="halId">hal-01380416</idno>
<idno type="halUri">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01380416</idno>
<idno type="url">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01380416</idno>
<idno type="doi">10.1080/21645515.2015.1126013</idno>
<date when="2016-02-02">2016-02-02</date>
<idno type="wicri:Area/Hal/Corpus">000207</idno>
<idno type="wicri:Area/Hal/Curation">000207</idno>
<idno type="wicri:Area/Hal/Checkpoint">000092</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000092</idno>
<idno type="wicri:doubleKey">2164-5515:2016:Rondy M:moderate:influenza:vaccine</idno>
<idno type="wicri:Area/Main/Merge">000383</idno>
<idno type="wicri:Area/Main/Curation">000383</idno>
<idno type="wicri:Area/Main/Exploration">000383</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network</title>
<author><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M." last="Rondy">M. Rondy</name>
</author>
<author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J." last="Castilla">J. Castilla</name>
</author>
<author><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O." last="Launay">O. Launay</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-2593" status="OLD"> <orgName>CIC - Biotherapie - AP-HP (cochin - Pasteur)</orgName>
<desc> <address> <addrLine>Hopital Cochin PARIS V 27, Rue du Faubourg Saint-Jacques 75679 PARIS CEDEX 14</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="CBT505" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="CBT505" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S." last="Costanzo">S. Costanzo</name>
</author>
<author><name sortKey="Ezpeleta, C" sort="Ezpeleta, C" uniqKey="Ezpeleta C" first="C." last="Ezpeleta">C. Ezpeleta</name>
</author>
<author><name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F." last="Galtier">F. Galtier</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-303483" status="VALID"> <orgName>CHU Saint-Eloi</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Gaetano Donati, K" sort="Gaetano Donati, K" uniqKey="Gaetano Donati K" first="K." last="Gaetano Donati">K. Gaetano Donati</name>
</author>
</analytic>
<idno type="DOI">10.1080/21645515.2015.1126013</idno>
<series><title level="j">Human Vaccines & Immunotherapeutics</title>
<idno type="ISSN">2164-5515</idno>
<imprint><date type="datePub">2016-02-02</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term>Influenza</term>
<term>Influenza vaccine</term>
<term>case control studies</term>
<term>hospital</term>
<term>multicentre studies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"> <p>We conducted a multicentre test negative case control study to estimate the 2013–14 influenza vaccine effectiveness (IVE) against hospitalised laboratory confirmed influenza in 12 hospitals in France, Italy and Spain. We included all ≥18 years hospitalised patients targeted by local influenza vaccination campaign reporting an influenza-like illness within 7 days before admission. We defined as cases patients RT-PCR positive for influenza and as controls those negative for all influenza virus. We used a logistic regression to calculate IVE adjusted for country, month of onset, chronic diseases and age. We included 104 A(H1N1)pdm09, 157 A(H3N2) cases and 585 controls. The adjusted IVE was 42.8% (95%CI: 6.3;65;0) against A(H1N1)pdm09. It was respectively 61.4% (95%CI: −1.9;85.4), 39.4% (95%CI: −32.2;72.2) and 19.7% (95%CI:-148.1;74.0) among patients aged 18–64, 65–79 and ≥80 years. The adjusted IVE against A(H3N2) was 38.1% (95%CI: 8.3;58.2) overall. It was respectively 7.8% (95%CI: −145.3;65.4), 25.6% (95%CI: −36.0;59.2) and 55.2% (95%CI: 15.4;76.3) among patients aged 18–64, 65–79 and ≥80 years. These results suggest a moderate and age varying effectiveness of the 2013–14 influenza vaccine to prevent hospitalised laboratory-confirmed influenza. While vaccination remains the most effective prevention measure, developing more immunogenic influenza vaccines is needed to prevent severe outcomes among target groups. © 2016 Taylor & Francis.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J." last="Castilla">J. Castilla</name>
<name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S." last="Costanzo">S. Costanzo</name>
<name sortKey="Ezpeleta, C" sort="Ezpeleta, C" uniqKey="Ezpeleta C" first="C." last="Ezpeleta">C. Ezpeleta</name>
<name sortKey="Gaetano Donati, K" sort="Gaetano Donati, K" uniqKey="Gaetano Donati K" first="K." last="Gaetano Donati">K. Gaetano Donati</name>
<name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M." last="Rondy">M. Rondy</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O." last="Launay">O. Launay</name>
</noRegion>
<name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F." last="Galtier">F. Galtier</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000383 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000383 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= Hal:hal-01380416 |texte= Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network }}
This area was generated with Dilib version V0.6.33. |